Vanessa Adame (United States of America)
University of Colorado Anschutz Medical Campus NeurologyPoster Author Of 1 e-Poster
OO029a - SHORT-TERM, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL SHOWS THAT GM-CSF/SARGRAMOSTIM TREATMENT LEADS TO IMPROVEMENTS IN MMSE AND BLOOD BIOMARKERS OF NEUROPATHOLOGY/NEURODEGENERATION (A, TAU, AND UCH-L1) (ID 1291)
Authors
- Huntington Potter (United States of America)
- Jonathan Woodcock (United States of America)
- Timothy Boyd (United States of America)
- Christina Coughlan (United States of America)
- John O'Shaughnessy (United States of America)
- Manuel Borges (United States of America)
- Ashesh Thaker (United States of America)
- Balaibail Raj (United States of America)
- Katarzyna Adamczuk (United States of America)
- David Scott (United States of America)
- Vanessa Adame (United States of America)
- Vanessa Adame (United States of America)
- Heidi Chial (United States of America)
- Helen Gray (United States of America)
- Michelle Stocker (United States of America)
- Stefan Sillau (United States of America)